Who is sponsoring NCT05153525?

NCT05153525 is sponsored by Tanta University.

What drugs are being tested in NCT05153525?

Interventions in NCT05153525: Intermittent boluses of Cisatracurium, Intravenous infusion of Cisatracurium for 24 hours.

What condition does NCT05153525 study?

NCT05153525 studies Respiratory Distress Syndrome, Pediatric, Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS).

Is NCT05153525 still recruiting?

NCT05153525 is currently status unknown. Last updated 22 June 2022.

Last reviewed 2022-06-22 · How we verify

NCT05153525

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Continuous Infusion Versus Intermittent Boluses of Cisatracurium in the Early Management of Pediatric ARDS

Status unknown Phase 4 Last updated 22 June 2022

What this trial tests

Phase 4 trial testing Intermittent boluses of Cisatracurium in Respiratory Distress Syndrome, Pediatric in 60 participants. Status unknown.

Timeline

6 January 2022

Primary endpoint
30 July 2022

5 August 2022

Quick facts

Lead sponsor	Tanta University
Phase	Phase 4
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	60
Start date	6 January 2022
Primary completion	30 July 2022
Estimated completion	5 August 2022
Sites	2 locations across Egypt

Drugs / interventions tested

Intermittent boluses of Cisatracurium — full drug profile →
Intravenous infusion of Cisatracurium for 24 hours — full drug profile →

Conditions studied

Respiratory Distress Syndrome, Pediatric — all drugs for Respiratory Distress Syndrome, Pediatric →
Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS) — all drugs for Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS) →

Sponsor

Tanta University

Who can join

Adults 1 Month to 18, any sex, with Respiratory Distress Syndrome, Pediatric or Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this work is to compare continuous infusion vs on need intermittent boluses of Cisatracurium in the early management of pediatric acute respiratory distress syndrome

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Challenges in ARDS Definition, Management, and Identification of Effective Personalized Therapies.
Battaglini D, Fazzini B, Silva PL, Cruz FF, et al · · 2023 · cited 48× · PMID 36835919 · DOI 10.3390/jcm12041381
Understanding clinical and biological heterogeneity to advance precision medicine in paediatric acute respiratory distress syndrome.
Kneyber MCJ, Khemani RG, Bhalla A, Blokpoel RGT, et al · · 2023 · cited 25× · PMID 36566767 · DOI 10.1016/s2213-2600(22)00483-0
Management of Neuromuscular Blocking Agents in Critically Ill Patients with Lung Diseases.
Iavarone IG, Al-Husinat L, Vélez-Páez JL, Robba C, et al · · 2024 · cited 7× · PMID 38398494 · DOI 10.3390/jcm13041182

Verify or expand the search:

Other Tanta University trials

Trials by the same sponsor.

NCT07398651 — Apremilast and Adalimumab in Psoriatic Arthritis Patients · NA · not yet recruiting
NCT06966856 — This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcti · Phase 3 · not yet recruiting
NCT07334197 — Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy · NA · not yet recruiting
NCT07498998 — Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome · NA · not yet recruiting
NCT07114250 — Comparative Study Between Spinal Anesthesia Versus General Anesthesia in Supine Percutaneous Nephrolithotomy Operation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05153525 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tanta University
Last refreshed: 22 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05153525.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing